Reference
Brecl Jakob G, et al. Effectiveness and safety of alemtuzumab in the treatment of active relapsing-remitting multiple sclerosis: a multicenter, observational study. Neurological Sciences 42: 4591-4597, No. 11, Nov 2021. Available from: URL: http://doi.org/10.1007/s10072-021-05145-x
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1896, 28 (2022). https://doi.org/10.1007/s40278-022-10819-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-10819-9